BOSTON ( TheStreet) -- Small-cap stocks have suffered a technical breakdown this quarter, with the Russell 2000 Index sliding 3.7% as blue-chips advance. If the market snaps back, these stocks are due for big gains.

These companies offer outstanding fundamentals and have earned "buy" ratings from our quantitative model. They're ordered by their potential to appreciate, starting with the company with the biggest growth prospects.

American Physicians Service Group ( AMPH) sells medical liability insurance and manages investments.

The numbers: Third-quarter net income fell 10% to $6.4 million, or 92 cents a share, as revenue grew 13% to $22 million. The company's gross margin fell from 64% to 49%, and its operating margin decreased from 56% to 43%. American Physicians has an admirable financial position, with $17 million of cash and $6.6 million of debt.

The stock: American Physicians has risen 11% this year, underperforming major U.S. benchmarks. The stock trades at a price-to-earnings ratio of 9, a discount to the market and insurers. The shares pay a 1.3% dividend yield.

Hawkins ( HWKN) makes chemicals used in water treatment, industrial production and drugs.

The numbers: Fiscal second-quarter net income declined 2% to $6.7 million, or 65 cents a share, as revenue dropped 17% to $65 million. The company's gross margin rose from 24% to 29%, and its operating margin increased from 14% to 17%. Hawkins has an ideal financial position, with $37 million of cash and no debt.

The stock: Hawkins has rallied 39% this year, beating major U.S. indices. The stock trades at a price-to-earnings ratio of 9, a discount to the market and chemical peers. The shares pay a 2.6% dividend yield.

National Bankshares ( NKSH) is a Virginia-based bank.

The numbers: Third-quarter net income increased 5% to $3.8 million, or 54 cents a share, as revenue inched up 1% to $15 million. The company's gross margin rose from 69% to 72%, and its operating margin advanced from 44% to 50%. National Bankshares has an ideal financial position, with $35 million of cash and minimal debt.

The stock: National Bankshares has increased 40% this year, outpacing major U.S. indices. The stock trades at a price-to-earnings ratio of 14, a discount to the market and regional banking peers. Shares pay a 3% dividend yield.

Peet's Coffee & Tea ( PEET) operates a chain of cafes and sells roasted whole beans in supermarkets.

The numbers: Third-quarter net income jumped 22% to $2.5 million, or 19 cents a share, as revenue grew 8% to $74 million. The company's gross margin rose from 18% to 19%, but its operating margin was unchanged at 5%. Peet's has an ideal financial position, with $21 million of cash and no debt.

The stock: Peet's has risen 61% this year, more than major U.S. indices. The stock trades at a price-to-earnings ratio of 38, a premium to the market and restaurant peers. The company doesn't pay dividends.

Neogen ( NEOG) sells food safety tests.

The numbers: Fiscal first-quarter net income increased 18% to $4.4 million, or 29 cents a share, as revenue grew 12% to $32 million. Neogen's gross margin rose from 55% to 57%, and its operating margin increased from 20% to 21%. The company has an ideal financial position, with $24 million of cash and no debt.

The stock: Neogen is up 25% this year, outpacing the Dow Jones Industrial Average and S&P 500 Index. The stock trades at a price-to-earnings ratio of 32, a premium to the market and health care supply peers. The company doesn't pay dividends.

-- Reported by Jake Lynch in Boston.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

The 6 Medications Being Used to Tackle the Opioid Epidemic

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

Electronic Arts, Activision Blizzard and Take-Two Interactive: 'Mad Money' Lightning Round

Electronic Arts, Activision Blizzard and Take-Two Interactive: 'Mad Money' Lightning Round

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)